Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril for prevention of aspiration pneumonia in stroke patients
IRCT20141121020020N6Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of captopril in aspiration pneumonia and stroke, sponsored by Babol University of Medical Sciences. Primary endpoint: Incidence of aspiration pneumonia. Started May 2017; status: completed.
02
Drugs
captopril
03
Conditions
aspiration pneumoniastroke
Beyond the preview
Go deeper on IRCT20141121020020N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141121020020N6.